ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting

Stock Information for Erytech Pharma S.A.

Loading

Please wait while we load your information from QuoteMedia.